Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Linezolid was approved in 2000 for treatment of gram-positive coccal infections. We performed a case-control study during a hospital outbreak of linezolid-resistant enterococci (LRE) infections, comparing cases of LRE infection (cases) with linezolid-sensitive enterococci infections (controls). Nasa...

Full description

Bibliographic Details
Main Authors: Marion A. Kainer, Rose A. Devasia, Timothy F. Jones, Bryan P. Simmons, Kelley Melton, Susan Chow, Joyce Broyles, Kelly L. Moore, Allen S. Craig, William Schaffner
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2007-07-01
Series:Emerging Infectious Diseases
Subjects:
Drug resistance
bacterial
enterococcus
oxazolidinones
antimicrobial agents
disease transmission
Online Access:https://wwwnc.cdc.gov/eid/article/13/7/07-0019_article

Internet

https://wwwnc.cdc.gov/eid/article/13/7/07-0019_article

Similar Items